According to the recent study the global needle-free injection system market is projected to reach an estimated $6 billion by 2030 from $2 billion in 2023 at a CAGR of 15% from 2023 to 2030. Growth in this market is primarily driven by growing prevalence of chronic diseases, the increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.
A more than 150-page
report to understand trends, opportunities and forecast in needle-free
injection system market by product (fillable needle-free injectors and
prefilled needle-free injectors), technology (jet-based needle-free injectors,
etc.), usability (reusable and disposable needle-free injectors), type of
medication (liquid-based needle-free injectors, powder-based needle-free
injectors, etc.), site of delivery (intradermal injectors, intramuscular
injectors, etc.), application (vaccine needle-free delivery, insulin
needle-free delivery, etc.), end users (hospitals and clinics, homecare
settings, etc.), and regions.
Based on technology, the
needle-free injection system market is segmented into jet-based needle-free
injectors, spring-based needle-free injectors, laser-powered needle-free
injectors, and vibration-based needle-free injectors. Lucintel forecasts that
the jet-based needle-free injector market is expected to remain the largest
segment accounted for the largest share as it helps in preventing needlestick
injuries to healthcare providers and overcomes the drawbacks of improper and
unsterile reuse of needles & syringes.
Download sample by clicking on
needle-free
injection system market.
Based on product the
prefilled needle-free injectors segment is expected to witness the highest
growth over the forecast period due to the majority of these prefilled syringes
are automated and thus reducing the risk of physical handling and ensuring a
safer use.
North America is
expected to remain the largest market during the forecast period mainly due
growing prevalence of chronic disease and rising demand for self-injection
systems contribute to North America driving the market. APAC is likely to
witness the highest growth over the forecast period due to the expansion of
private-sector hospitals and clinics to rural areas, the availability of low-cost
labor for manufacturing.
Major players of
needle-free injection system market are adopting various growth strategies like
new product launches, expansions, merger and acquisitions, partnerships,
agreements, and collaborations to expand their presence in this market. Endo
International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical
International Technology Inc., PharmaJet are among the major needle-free
injection system providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment